MedTrace Logo

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

NCT06370780 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-10-03

No results posted yet for this study

Summary

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

Conditions

  • HIV Infections

Interventions

OTHER

EPI LOVE

Observational cohort only

Sponsors & Collaborators

  • Florida State University

    collaborator OTHER

  • University of California, Irvine

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • AIDS Healthcare Foundation

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of California, Los Angeles

    lead OTHER

Principal Investigators

  • Pamina Gorbach, DrPh · University of California, Los Angeles

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-09
Primary Completion
2028-04-30
Completion
2028-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06370780 on ClinicalTrials.gov